Global pharmaceutical leader Lupin Limited (Lupin) has announced the completion of a strategic acquisition through its European hub, Lupin Atlantis Holdings SA. The company has acquired the well-established brands Aarane and Nalcrom from Sanofi, encompassing operations in Germany, Canada, and the Netherlands. This acquisition includes trademark rights and is set to significantly enhance Lupin’s position […]
Glenmark Pharmaceuticals Limited, a research-led, global pharmaceutical company, today released its financial results for the fourth quarter ending March 31, 2024, showcasing a solid performance across its diversified markets despite some challenges in North America. Glenmark Pharmaceuticals Financial Highlights and Performance For the fourth quarter of FY 2023-24, Glenmark reported a consolidated revenue of Rs. […]
Sanjivani Paranteral Ltd (BSE: 531569), a renowned pharmaceutical company based in Mumbai with manufacturing facilities in Navi Mumbai and Dehradun, has announced impressive financial results for the fourth quarter of FY24, showcasing significant growth and strategic expansions. Financial Performance Highlights: In Q4 FY24, Sanjivani Paranteral reported a substantial increase in revenue, which grew 58.38% year-over-year […]
Gland Pharma Limited, a prominent player in the generic injectable-focused pharmaceutical industry, has received approval from the United States Food and Drug Administration (USFDA) for its Edaravone Injection. This approval marks a significant milestone for the company as it prepares to offer new therapeutic options for patients suffering from amyotrophic lateral sclerosis (ALS). Product Details […]
AstraZeneca PLC has reported a notable performance in the first quarter of 2024, with total revenue reaching $12,679 million, marking a 19% increase at constant exchange rates (CER). The increase was primarily driven by an 18% rise in product sales, bolstered by significant growth in alliance revenue, which surged by 59% at CER. The company […]
Eli Lilly and Company (NYSE: LLY) has released positive topline results from the phase 3 SURMOUNT-OSA clinical trials, demonstrating that tirzepatide injection significantly reduces the apnea-hypopnea index (AHI) compared to placebo. Tirzepatide, already known for chronic weight management under the brand names Zepbound in the U.S. and Mounjaro globally, now shows promise in treating moderate-to-severe […]
In a strategic move that significantly escalates its capacity in the biologics manufacturing landscape, Lonza, a key global player in manufacturing for the pharmaceutical, biotech, and nutraceutical markets, announced its acquisition of Genentech’s large-scale biologics manufacturing facility in Vacaville, California, from Roche for USD 1.2 billion. This acquisition marks a significant expansion of Lonza’s manufacturing […]
In a significant development for the pharmaceutical industry, Zydus Lifesciences Limited, previously known as Cadila Healthcare Limited, has secured final approval from the United States Food and Drug Administration (USFDA) to market its combination drug, Finasteride and Tadalafil Capsules USP, 5 mg/5 mg. This approval, announced recently, positions Zydus as the inaugural approved applicant for […]
In a strategic move that reshapes the landscape of India’s injectables market, Eris Lifesciences Ltd., a leading player in the branded formulations sector, has announced the acquisition of Biocon Biologics’ India branded formulation business for a hefty sum of INR 1,242 crore. This acquisition not only signifies Eris Lifesciences’ aggressive entry into the burgeoning INR […]
In a notable advancement for neuropathic pain treatment, Strides Pharma Science Limited (Strides) has announced that its step-down wholly owned subsidiary, Strides Pharma Global Pte. Limited, Singapore, has received the United States Food & Drug Administration (USFDA) approval for Gabapentin Tablets USP, 600 mg and 800 mg. This approval marks a significant milestone for Strides, […]